Chugai Pharmaceutical and Biofourmis have formed a partnership to develop digital solutions for pain management in patients with endometriosis. The companies have been working together since July 2020 to develop objective assessment of pain associated with the disease, which has resulted in the utilization of Biofourmis’ Biovitals platform for a biosensor and AI-based algorithm. Chugai, headquartered in Tokyo, is a research-based pharmaceutical…
Egal, a company dedicated to achieving equality for periods in restrooms, is launching a new menstrual pad that will be as easily accessible as toilet paper. Despite 300 million people menstruating daily, the unpredictability of periods and lack of access to period products can result in embarrassment, missed work or school. Egal is launching its product with $1 million investment angel funding,…
Endometriosis is a debilitating condition that affects one in ten women of reproductive age, causing excessive bleeding, inflammation, and debilitating pain. The disease occurs when tissue that usually lines the inside of the uterus grows outside the womb and attaches to other organs in the body. The condition can significantly impact a person’s quality of life and their ability to work, study,…
At the start of each week we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about… Innovation in Endometriosis Diagnostics & Care Innovation in Endometriosis Diagnostics & Care 👉 Endometriosis 101 You’ve found some of our exclusive Inner Circle Content. This…
Qvin, the biotech company that developed a healthcare solution that collects menstrual blood to test for HR-HPV and other critical healthcare information, has received FDA approval in Thailand for its Q-Pad technology. This approval will make it possible for Thailand residents who menstruate to test for HR-HPV with Qvin’s Q-Pad this year. Thailand has a population of 30 million women ages 15 years and older who are at…
Apple’s Women’s Health Study set out to identify abnormal uterine bleeding (AUB) patterns and their prevalence in participants and to confirm existing and expected associations between AUB patterns, demographics, and medical conditions. The results are in, have been published in AJOG, and suggest that 16.4% of women in the study experience AUB. 2.9% had irregular menses, 8.4% had infrequent menses, 2.3% had…
UK-based biotech startup Emm, has developed a novel smart menstrual cup that uses proprietary sensing technology to monitor and analyze specific biometrics to empower and inform the user through unique health insights and data regarding their menstrual cycle. Having closed its pre-seed funding of over $1M, it is now in beta-testing, readying for full production and launch in 2023. Emm was founded…
Elix, the first digital platform to combine Traditional Chinese Medicine (TCM) with a proprietary algorithm to empower self-healinghas announced the results of a clinical trial that validates the efficacy of its signature product, Cycle Balance, a personalized formula of medicinal herbs. Cycle Balance holistically supports menstrual symptoms by treating underlying hormonal imbalances, on significantly reducing the severity of 15 common menstrual symptoms…
